Last reviewed · How we verify
Budesonida Pulmictan® 200 µg
Budesonida Pulmictan® 200 µg is a Small molecule drug developed by Reig Jofre Group. It is currently in Phase 1 development. Also known as: Budesonide 200 µg (reference product (A))..
At a glance
| Generic name | Budesonida Pulmictan® 200 µg |
|---|---|
| Also known as | Budesonide 200 µg (reference product (A)). |
| Sponsor | Reig Jofre Group |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Budesonida Pulmictan® 200 µg CI brief — competitive landscape report
- Budesonida Pulmictan® 200 µg updates RSS · CI watch RSS
- Reig Jofre Group portfolio CI
Frequently asked questions about Budesonida Pulmictan® 200 µg
What is Budesonida Pulmictan® 200 µg?
Budesonida Pulmictan® 200 µg is a Small molecule drug developed by Reig Jofre Group.
Who makes Budesonida Pulmictan® 200 µg?
Budesonida Pulmictan® 200 µg is developed by Reig Jofre Group (see full Reig Jofre Group pipeline at /company/reig-jofre-group).
Is Budesonida Pulmictan® 200 µg also known as anything else?
Budesonida Pulmictan® 200 µg is also known as Budesonide 200 µg (reference product (A))..
What development phase is Budesonida Pulmictan® 200 µg in?
Budesonida Pulmictan® 200 µg is in Phase 1.
Related
- Manufacturer: Reig Jofre Group — full pipeline
- Also known as: Budesonide 200 µg (reference product (A)).
- Compare: Budesonida Pulmictan® 200 µg vs similar drugs
- Pricing: Budesonida Pulmictan® 200 µg cost, discount & access